{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:47:11Z","timestamp":1773334031781,"version":"3.50.1"},"reference-count":311,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/01227\/2015"],"award-info":[{"award-number":["IF\/01227\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/BIM\/50005\/2019"],"award-info":[{"award-number":["UID\/BIM\/50005\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epilepsy is one of the most common brain diseases worldwide, having a huge burden in society. The main hallmark of epilepsy is the occurrence of spontaneous recurrent seizures, having a tremendous impact on the lives of the patients and of their relatives. Currently, the therapeutic strategies are mostly based on the use of antiepileptic drugs, and because several types of epilepsies are of unknown origin, a high percentage of patients are resistant to the available pharmacotherapy, continuing to experience seizures overtime. Therefore, the search for new drugs and therapeutic targets is highly important. One key aspect to be targeted is the aberrant adult hippocampal neurogenesis (AHN) derived from Neural Stem Cells (NSCs). Indeed, targeting seizure-induced AHN may reduce recurrent seizures and shed some light on the mechanisms of disease. The endocannabinoid system is a known modulator of AHN, and due to the known endogenous antiepileptic properties, it is an interesting candidate for the generation of new antiepileptic drugs. However, further studies and clinical trials are required to investigate the putative mechanisms by which cannabinoids can be used to treat epilepsy. In this manuscript, we will review how cannabinoid-induced modulation of NSCs may promote neural plasticity and whether these drugs can be used as putative antiepileptic treatment.<\/jats:p>","DOI":"10.3390\/ijms21197309","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T07:22:16Z","timestamp":1601709736000},"page":"7309","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-0315","authenticated-orcid":false,"given":"Diogo M.","family":"Louren\u00e7o","sequence":"first","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-8210","authenticated-orcid":false,"given":"Leonor","family":"Ribeiro-Rodrigues","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-6115","authenticated-orcid":false,"given":"Ana M.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-6246","authenticated-orcid":false,"given":"Maria J.","family":"Di\u00f3genes","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-2509","authenticated-orcid":false,"given":"Sara","family":"Xapelli","sequence":"additional","affiliation":[{"name":"Instituto de Farmacologia e Neuroci\u00eancias, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"},{"name":"Instituto de Medicina Molecular Jo\u00e3o Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yebeh.2009.10.023","article-title":"Hallmarks in the history of epilepsy: Epilepsy in antiquity","volume":"17","author":"Magiorkinis","year":"2010","journal-title":"Epilepsy Behav."},{"key":"ref_2","unstructured":"Global Campaign against Epilepsy, International Bureau of Epilepsy, and International League against Epilepsy (2005). WHO|Atlas: Epilepsy Care in the World, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy","volume":"264","author":"Manford","year":"2017","journal-title":"J. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Parent, J.M., and Kron, M.M. (2012). Neurogenesis and Epilepsy. Jasper\u2019s Basic Mechanisms of the Epilepsies, Oxford University Press.","DOI":"10.1093\/med\/9780199746545.003.0038"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11910-015-0616-3","article-title":"Neurogenesis in the Hippocampus of Patients with Temporal Lobe Epilepsy","volume":"16","author":"Zhong","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41380-018-0036-2","article-title":"The role of adult hippocampal neurogenesis in brain health and disease","volume":"24","author":"Toda","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"Cannabinoids and Epilepsy","volume":"12","author":"Rosenberg","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gloss, D., and Vickrey, B. (2014). Cannabinoids for epilepsy. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD009270.pub3"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1111\/bph.13186","article-title":"The role of cannabinoids in adult neurogenesis: Cannabinoids and neurogenesis","volume":"172","author":"Prenderville","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","unstructured":"WHO (2019). Epilepsy: A Public Health Imperative, WHO."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and life-time epilepsy: A meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"Feigin","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/epi.13671","article-title":"Instruction manual for the ILAE 2017 operational classification of seizure types","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"a022822","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Lukasiuk","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrn3482","article-title":"Mechanisms of epileptogenesis: A convergence on neural circuit dysfunction","volume":"14","author":"Goldberg","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1474-4422(10)70310-0","article-title":"Mechanisms of epileptogenesis and potential treatment targets","volume":"10","author":"Lukasiuk","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/epi.13965","article-title":"Commonalities in epileptogenic processes from different acute brain insults: Do they translate?","volume":"59","author":"Klein","year":"2018","journal-title":"Epilepsia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jnr.20802","article-title":"Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy","volume":"83","author":"Rao","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1523\/JNEUROSCI.23-06-02440.2003","article-title":"Reduced Inhibition of Dentate Granule Cells in a Model of Temporal Lobe Epilepsy","volume":"23","author":"Kobayashi","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fcell.2019.00158","article-title":"Reactive Disruption of the Hippocampal Neurogenic Niche After Induction of Seizures by Injection of Kainic Acid in the Amygdala","volume":"7","author":"Espinosa","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"Redeker","year":"2007","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/2661","article-title":"Selective changes in single cell GABA A receptor subunit expression and function in temporal lobe epilepsy","volume":"4","author":"Shumate","year":"1998","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fncel.2019.00004","article-title":"Loss of TrkB Signaling Due to Status Epilepticus Induces a proBDNF-Dependent Cell Death","volume":"13","author":"Montroull","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","article-title":"The kainic acid model of temporal lobe epilepsy","volume":"37","author":"Avoli","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Scharfman, H.E., and Myers, C.E. (2013). Hilar mossy cells of the dentate gyrus: A historical perspective. Front. Neural Circuits, 6.","DOI":"10.3389\/fncir.2012.00106"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.3390\/ijms140918284","article-title":"Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions","volume":"14","author":"Reddy","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106285","DOI":"10.1016\/j.yebeh.2019.04.038","article-title":"Blood\u2013brain barrier dysfunction in status epileptics: Mechanisms and role in epileptogenesis","volume":"101","author":"Swissa","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbadis.2017.02.003","article-title":"Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy","volume":"1863","author":"Clossen","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_36","first-page":"107855","article-title":"Why we urgently need improved epilepsy therapies for adult patients","volume":"18","author":"Billakota","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: Use and limitations","volume":"10","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/B978-0-12-394596-9.00003-2","article-title":"Experimental Models of Seizures and Epilepsies","volume":"Volume 105","author":"Raol","year":"2012","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(02)00073-6","article-title":"Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy","volume":"50","year":"2002","journal-title":"Epilepsy Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/ebeh.2001.0193","article-title":"Overview of the Current Animal Models for Human Seizure and Epileptic Disorders","volume":"2","author":"Sarkisian","year":"2001","journal-title":"Epilepsy Behav."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneumeth.2015.10.006","article-title":"Models of drug-induced epileptiform synchronization in vitro","volume":"260","author":"Avoli","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","article-title":"Mammalian neural stem cells","volume":"287","author":"Gage","year":"2000","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rodrigues, R., Louren\u00e7o, D., Paulo, S., Mateus, J., Ferreira, M., Mouro, F., Moreira, J., Ribeiro, F., Sebasti\u00e3o, A., and Xapelli, S. (2019). Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. Molecules, 24.","DOI":"10.3390\/molecules24071350"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","article-title":"The dentate gyrus: Fundamental neuroanatomical organization (dentate gyrus for dummies)","volume":"Volume 163","author":"Amaral","year":"2007","journal-title":"Progress in Brain Research"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Santos, V.R., santana Melo, I., Pacheco, A.L.D., and de Castro, O.W. (2019). Life and death in the hippocampus: What\u2019s bad?. Epilepsy Behav., 106595.","DOI":"10.1016\/j.yebeh.2019.106595"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nature11306","article-title":"Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision","volume":"489","author":"Song","year":"2012","journal-title":"Nature"},{"key":"ref_47","first-page":"362","article-title":"Different Mechanisms Must Be Considered to Explain the Increase in Hippocampal Neural Precursor Cell Proliferation by Physical Activity","volume":"1","author":"Malva","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2005.08.023","article-title":"GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells","volume":"47","author":"Tozuka","year":"2005","journal-title":"Neuron"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ge, S., Goh, E.L.K., Sailor, K.A., Kitabatake, Y., Ming, G., and Song, H. (2006). GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature.","DOI":"10.1038\/nature04404"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1460-9568.2005.04377.x","article-title":"Increased generation of granule cells in adult Bcl-2-overexpressing mice: A role for cell death during continued hippocampal neurogenesis","volume":"22","author":"Kuhn","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(00)01368-9","article-title":"Analysis of neurogenesis and programmed cell death reveals a self- renewing capacity in the adult rat brain","volume":"291","author":"Biebl","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"a018978","DOI":"10.1101\/cshperspect.a018978","article-title":"Functional Differentiation of Adult-Born Neurons along the Septotemporal Axis of the Dentate Gyrus","volume":"7","author":"Wu","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn2822","article-title":"New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory?","volume":"11","author":"Deng","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112032","DOI":"10.1016\/j.bbr.2019.112032","article-title":"Insult-induced aberrant hippocampal neurogenesis: Functional consequences and possible therapeutic strategies","volume":"372","author":"Bielefeld","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"a020677","DOI":"10.1101\/cshperspect.a020677","article-title":"Epilepsy and Adult Neurogenesis","volume":"7","author":"Jessberger","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.expneurol.2006.08.023","article-title":"Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients","volume":"203","author":"Fahrner","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hipo.1045","article-title":"Increase of nestin-immunoreactive neural precursor cells in the dentate gyrus of pediatric patients with early-onset temporal lobe epilepsy: Increased Hippocampal Neurogenesis in Human TLE","volume":"11","author":"Schewe","year":"2001","journal-title":"Hippocampus"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bielefeld, P., Schouten, M., Meijer, G.M., Breuk, M.J., Geijtenbeek, K., Karayel, S., Tiaglik, A., Vuuregge, A.H., Willems, R.A.L., and Witkamp, D. (2019). Co-administration of Anti microRNA-124 and -137 Oligonucleotides Prevents Hippocampal Neural Stem Cell Loss Upon Non-convulsive Seizures. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00031"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.stem.2015.04.003","article-title":"Neuronal Hyperactivity Accelerates Depletion of Neural Stem Cells and Impairs Hippocampal Neurogenesis","volume":"16","author":"Sierra","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2015.04.046","article-title":"Aberrant hippocampal neurogenesis after limbic kindling: Relationship to BDNF and hippocampal-dependent memory","volume":"47","author":"Botterill","year":"2015","journal-title":"Epilepsy Behav."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q","article-title":"Status epilepticus-induced hilar basal dendrites on rodent granule cells contribute to recurrent excitatory circuitry","volume":"428","author":"Ribak","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eplepsyres.2005.12.003","article-title":"Newly born dentate granule neurons after pilocarpine-induced epilepsy have hilar basal dendrites with immature synapses","volume":"69","author":"Shapiro","year":"2006","journal-title":"Epilepsy Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1523\/JNEUROSCI.17-10-03727.1997","article-title":"Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus","volume":"17","author":"Parent","year":"1997","journal-title":"J. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.expneurol.2005.08.010","article-title":"Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells","volume":"196","author":"Jessberger","year":"2005","journal-title":"Exp. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1523\/JNEUROSCI.3111-06.2007","article-title":"Reelin Regulates Neuronal Progenitor Migration in Intact and Epileptic Hippocampus","volume":"27","author":"Gong","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0306-4522(03)00481-0","article-title":"Perforant path activation of ectopic granule cells that are born after pilocarpine-induced seizures","volume":"121","author":"Scharfman","year":"2003","journal-title":"Neuroscience"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.20-16-06144.2000","article-title":"Granule-like neurons at the hilar\/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: Functional implications of seizure-induced neurogenesis","volume":"20","author":"Scharfman","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1523\/JNEUROSCI.0110-07.2007","article-title":"Epigenetic Modulation of Seizure-Induced Neurogenesis and Cognitive Decline","volume":"27","author":"Jessberger","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Joubert, B., Belbezier, A., Haesebaert, J., Rheims, S., Ducray, F., Picard, G., Rogemond, V., Psimaras, D., Berzero, G., and Desestret, V. (2020). Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies. J. Neurol.","DOI":"10.1007\/s00415-020-09807-2"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0079-6123(02)35041-6","article-title":"Effects of chronic epilepsy on declarative memory systems","volume":"Volume 135","author":"Helmstaedter","year":"2002","journal-title":"Progress in Brain Research"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neuron.2006.11.004","article-title":"Environment Matters: Synaptic Properties of Neurons Born in the Epileptic Adult Brain Develop to Reduce Excitability","volume":"52","author":"Jakubs","year":"2006","journal-title":"Neuron"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/j.1528-1167.2007.01146.x","article-title":"Radiation of the Rat Brain Suppresses Seizure-Induced Neurogenesis and Transiently Enhances Excitability during Kindling Acquisition","volume":"48","author":"Raedt","year":"2007","journal-title":"Epilepsia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/hipo.20802","article-title":"Modulation of neurogenesis by targeted hippocampal irradiation fails to affect kindling progression","volume":"21","author":"Pekcec","year":"2011","journal-title":"Hippocampus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1111\/j.0953-816X.2004.03412.x","article-title":"Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"19","author":"Jung","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1038\/ncomms7606","article-title":"Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline","volume":"6","author":"Cho","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lfs.2017.07.028","article-title":"Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt\/\u03b2-catenin pathway","volume":"185","author":"Wang","year":"2017","journal-title":"Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.stemcr.2015.10.012","article-title":"Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid","volume":"5","author":"Juliandi","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","article-title":"Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-\u03b2 Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)\/Akt\/Wnt\/\u03b2-Catenin Pathway","volume":"290","author":"Tiwari","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejpn.2007.02.006","article-title":"Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs","volume":"11","author":"Ikonomidou","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lutes, J.M. (2018). Chapter 44-Developmental Neurotoxicology of Antiepileptic Drugs. Handbook of Developmental Neurotoxicology, Academic Press. [2nd ed.].","DOI":"10.1016\/B978-0-12-809405-1.00044-4"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.reprotox.2016.06.007","article-title":"The treatment of epilepsy in pregnancy: The neurodevelopmental risks associated with exposure to antiepileptic drugs","volume":"64","author":"Bromley","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eplepsyres.2009.09.019","article-title":"Antiepileptic drugs and brain development","volume":"88","author":"Ikonomidou","year":"2010","journal-title":"Epilepsy Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18015","DOI":"10.1038\/s41598-017-18237-6","article-title":"Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression","volume":"7","author":"Hosford","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fnmol.2018.00442","article-title":"MicroRNA-22 Controls Aberrant Neurogenesis and Changes in Neuronal Morphology After Status Epilepticus","volume":"11","author":"Beamer","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1038\/srep17486","article-title":"MicroRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus","volume":"5","author":"Concannon","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nm.2834","article-title":"Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects","volume":"18","author":"Engel","year":"2012","journal-title":"Nat. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fncel.2019.00145","article-title":"Silencing MicroRNA-134 Alleviates Hippocampal Damage and Occurrence of Spontaneous Seizures After Intraventricular Kainic Acid-Induced Status Epilepticus in Rats","volume":"13","author":"Gao","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00429-014-0798-5","article-title":"Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus","volume":"220","author":"Engel","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1523\/JNEUROSCI.3014-18.2019","article-title":"Antagonizing increased miR-135a levels at the chronic stage of experimental TLE reduces spontaneous recurrent seizures","volume":"39","author":"Vangoor","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.stemcr.2019.04.020","article-title":"MiR-135a-5p Is Critical for Exercise-Induced Adult Neurogenesis","volume":"12","author":"Gasperini","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_92","unstructured":"(2019, November 24). FDA Approves First-Of-Its Kind Targeted RNA-Based Therapy to Treat a Rare Disease, FDA, (n.d.), Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2019.04.042","article-title":"Novel therapies for epilepsy in the pipeline","volume":"97","author":"Mesraoua","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lybrand, Z.R., Goswami, S., and Hsieh, J. (2019). Stem cells: A path towards improved epilepsy therapies. Neuropharmacology, 107781.","DOI":"10.1016\/j.neuropharm.2019.107781"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2014.10.006","article-title":"hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice","volume":"15","author":"Cunningham","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1073\/pnas.1814185115","article-title":"Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration","volume":"116","author":"Upadhya","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous Induced Stem-Cell\u2013Derived Retinal Cells for Macular Degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/rme-2018-0158","article-title":"Preparing for first human trial of induced pluripotent stem cell-derived cells for Parkinson\u2019s disease: An interview with Jun Takahashi","volume":"14","author":"Takahashi","year":"2019","journal-title":"Regen. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Upadhya, D., and Shetty, A.K. (2019). Promise of extracellular vesicles for diagnosis and treatment of epilepsy. Epilepsy Behav., 106499.","DOI":"10.1016\/j.yebeh.2019.106499"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Karttunen, J., Heiskanen, M., Lipponen, A., Poulsen, D., and Pitk\u00e4nen, A. (2019). Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061259"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"E3536","DOI":"10.1073\/pnas.1703920114","article-title":"Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus","volume":"114","author":"Long","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/can.2018.0039","article-title":"Cannabis Systematics at the Levels of Family, Genus, and Species","volume":"3","author":"McPartland","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Solymosi, K., and Kofalvi, A. (2017). Cannabis: A Treasure Trove or Pandora\u2019s Box?. Mini Rev. Med. Chem., 17.","DOI":"10.2174\/1389557516666161004162133"},{"key":"ref_104","unstructured":"United Nations Office on Drugs and Crime (2019). World Drug Report 2019 Booklet 5: \u201cCannabis and Hallucinogens\u201d, United Nations. S.l., United Nations Publication."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-45541-9_4","article-title":"Molecular Targets of the Phytocannabinoids: A Complex Picture","volume":"Volume 103","author":"Kinghorn","year":"2017","journal-title":"Phytocannabinoids"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1360-0443.1996.911115852.x","article-title":"Cannabis: Pharmacology and toxicology in animals and humans","volume":"91","author":"Adams","year":"1996","journal-title":"Addiction"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2016.04.009","article-title":"Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis","volume":"113","author":"Fitzpatrick","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Rice, J., and Cameron, M. (2018). Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Curr. Neurol. Neurosci. Rep., 18.","DOI":"10.1007\/s11910-018-0859-x"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/epi.12610","article-title":"The case for medical marijuana in epilepsy","volume":"55","author":"Maa","year":"2014","journal-title":"Epilepsia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/bph.12492","article-title":"The influence of cannabinoids on generic traits of neurodegeneration","volume":"171","author":"Fagan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jnc.14098","article-title":"Endocannabinoid system in neurodegenerative disorders","volume":"142","author":"Basavarajappa","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","article-title":"Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer\u2019s disease and levodopa-induced dyskinesia","volume":"67","author":"Navarro","year":"2018","journal-title":"BrainBehav. Immun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/pmt.14.49","article-title":"Re-branding cannabis: The next generation of chronic pain medicine?","volume":"5","author":"Carter","year":"2015","journal-title":"Pain Manag."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Pamplona, F.A., da Silva, L.R., and Coan, A.C. (2018). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00759"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcp.2018.07.033","article-title":"Chronic pain and cannabinoids. Great expectations or a christmas carol","volume":"157","author":"Pascual","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.20111","article-title":"Survey on cannabis use in Parkinson\u2019s disease: Subjective improvement of motor symptoms","volume":"19","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jagp.2012.11.022","article-title":"Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms","volume":"22","author":"Woodward","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Gado, F., Digiacomo, M., Macchia, M., Bertini, S., and Manera, C. (2018). Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis. Medicines, 5.","DOI":"10.3390\/medicines5030091"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/da.20248","article-title":"Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial","volume":"24","author":"Bricker","year":"2007","journal-title":"Depress. Anxiety"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Patel, R.S., Kamil, S., Shah, M.R., Bhimanadham, N.N., and Imran, S. (2019). Pros and Cons of Marijuana in Treatment of Parkinson\u2019s Disease. Cureus.","DOI":"10.7759\/cureus.4813"},{"key":"ref_123","first-page":"33","article-title":"Marijuana for Parkinson\u2019s Disease?","volume":"16","author":"Mohanty","year":"2019","journal-title":"Innov. Clin. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1574884711666160418105339","article-title":"Endocannabinoid System: A Multi-Facet Therapeutic Target","volume":"11","author":"Kaur","year":"2016","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"413S","DOI":"10.1002\/j.1552-4604.1981.tb02621.x","article-title":"Treatment of Human Spasticity with \u03949-Tetrahydrocannabinol","volume":"21","author":"Petro","year":"1981","journal-title":"J. Clin. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/npp.2011.19","article-title":"The Cannabinoid Receptor Agonist THC Attenuates Weight Loss in a Rodent Model of Activity-Based Anorexia","volume":"36","author":"Verty","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.1979.tb127271.x","article-title":"Amelioration Of Cancer Chemotherapy-Induced Nausea and Vomiting by Delta-9-Tetrahydro-Cannabinol","volume":"2","author":"Ekert","year":"1979","journal-title":"Med. J. Aust."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAI.0b013e31811ed205","article-title":"Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep","volume":"45","author":"Haney","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-45541-9_1","article-title":"Phytochemistry of Cannabis sativa L.","volume":"Volume 103","author":"Kinghorn","year":"2017","journal-title":"Phytocannabinoids"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Abush, H., and Akirav, I. (2012). Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031731"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The Pharmacologic and Clinical Effects of Medical Cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and Schizophrenia: A Longitudinal Study of Swedish Conscripts","volume":"330","author":"Allebeck","year":"1987","journal-title":"Lancet"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(09)61037-0","article-title":"Adverse health effects of non-medical cannabis use","volume":"374","author":"Hall","year":"2009","journal-title":"Lancet"},{"key":"ref_134","first-page":"44","article-title":"Cannabis-Induced Bipolar Disorder with Psychotic Features: A Case Report","volume":"6","author":"Khan","year":"2009","journal-title":"Psychiatry Edgmont"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/3-540-26573-2_24","article-title":"Cannabinoid Tolerance and Dependence","volume":"Volume 168","author":"Pertwee","year":"2005","journal-title":"Cannabinoids"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1054\/plef.2001.0347","article-title":"The endocannabinoid system in invertebrates","volume":"66","author":"Salzet","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids Plefa"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2019.11.002","article-title":"Missing Pieces to the Endocannabinoid Puzzle","volume":"26","author":"Maccarrone","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/febs.12212","article-title":"Transport of endocannabinoids across the plasma membrane and within the cell","volume":"280","author":"Fowler","year":"2013","journal-title":"Febs J."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Lajtha, A., Tettamanti, G., and Goracci, G. (2009). The Endocannabinoid System and its Manifold Central Actions. Handbook of Neurochemistry and Molecular Neurobiology: Neural Lipids, Springer.","DOI":"10.1007\/978-0-387-30378-9"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-6980(00)00051-4","article-title":"Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol","volume":"61","author":"Hillard","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-Mediated Control of Synaptic Transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid Signaling and Synaptic Function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Storozhuk, M.V., and Zholos, A.V. (2018). TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling. Curr. Neuropharmacol., 16.","DOI":"10.2174\/1570159X15666170424120802"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Marzo","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/er.2006-0006","article-title":"Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility","volume":"27","author":"Wang","year":"2006","journal-title":"Endocr. Rev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: The endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pnpbp.2015.03.006","article-title":"For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders","volume":"64","author":"Henry","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"111881","DOI":"10.1016\/j.yexcr.2020.111881","article-title":"The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs","volume":"389","author":"Ruhl","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.11.014","article-title":"Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets","volume":"128","author":"Mallipeddi","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB 1 and CB 2 Receptor Pharmacology","volume":"Volume 80","author":"Howlett","year":"2017","journal-title":"Advances in Pharmacology"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"RC174","DOI":"10.1523\/JNEUROSCI.21-20-j0005.2001","article-title":"Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids","volume":"21","author":"Kreitzer","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12017-014-8314-x","article-title":"Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood\u2013Brain Barrier","volume":"16","author":"Vendel","year":"2014","journal-title":"Neuromol. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity","volume":"43","author":"Bains","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Cassano, T., Calcagnini, S., Pace, L., De Marco, F., Romano, A., and Gaetani, S. (2017). Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. Front. Neurosci., 11.","DOI":"10.3389\/fnins.2017.00030"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Stella","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in Neurodegenerative Disorders and Stroke\/Brain Trauma: From Preclinical Models to Clinical Applications","volume":"12","author":"Moro","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/plef.2001.0360","article-title":"Endocannabinoids in the central nervous system\u2013an overview","volume":"66","author":"Fride","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","article-title":"Progress in brain cannabinoid CB2 receptor research: From genes to behavior","volume":"98","author":"Jordan","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: The first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"PL1","DOI":"10.1016\/S0024-3205(98)00238-0","article-title":"Complex pharmacology of natural cannabinoids: Evidence for partial agonist activity of \u03949-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881108089870","article-title":"Modelling of the concentration\u2014Effect relationship of THC on central nervous system parameters and heart rate\u2014Insight into its mechanisms of action and a tool for clinical research and development of cannabinoids","volume":"22","author":"Strougo","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-007-0861-5","article-title":"Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users","volume":"194","author":"Huestis","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/acsmedchemlett.9b00127","article-title":"CBD: A New Hope?","volume":"10","author":"Morales","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17512433.2017.1292849","article-title":"Cannabinoids therapeutic use: What is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular Targets of Cannabidiol in Neurological Disorders","volume":"12","author":"Chen","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro: Cannabinoid antagonism by cannabidiol","volume":"150","author":"Thomas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Fride","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/17512433.2020.1721281","article-title":"The \u2018entourage effect\u2019 or \u2018hodge-podge hashish\u2019: The questionable rebranding, marketing, and expectations of cannabis polypharmacy","volume":"13","author":"Cogan","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_183","first-page":"255","article-title":"Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry","volume":"1862","author":"Lerner","year":"2017","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Biol. Lipids"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eplepsyres.2015.01.003","article-title":"Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs","volume":"111","author":"Shubina","year":"2015","journal-title":"Epilepsy Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yebeh.2018.12.001","article-title":"Early endocannabinoid system activation attenuates behavioral impairments induced by initial impact but does not prevent epileptogenesis in lithium\u2013pilocarpine status epilepticus model","volume":"92","author":"Suleymanova","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.celrep.2016.06.083","article-title":"Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures","volume":"16","author":"Sugaya","year":"2016","journal-title":"Cell Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.02.003","article-title":"Endocannabinoid-dependent protection against kainic acid-induced long-term alteration of brain oscillations in guinea pigs","volume":"1661","author":"Shubina","year":"2017","journal-title":"Brain Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2014.08.001","article-title":"Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm","volume":"73","author":"Jafari","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Guggenhuber, S., Monory, K., Lutz, B., and Klugmann, M. (2010). AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015707"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1523\/JNEUROSCI.4465-07.2008","article-title":"Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus","volume":"28","author":"Eross","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2015.09.008","article-title":"Pilocarpine-induced status epilepticus in mice: A comparison of spectral analysis of electroencephalogram and behavioral grading using the Racine scale","volume":"117","author":"Phelan","year":"2015","journal-title":"Epilepsy Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1528-1167.2010.02624.x","article-title":"Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans: CB1-R Expressing GABAergic Fibers in TLE","volume":"51","author":"Nagy","year":"2010","journal-title":"Epilepsia"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Karl\u00f3cai, M.R., T\u00f3th, K., Watanabe, M., Ledent, C., Juh\u00e1sz, G., Freund, T.F., and Magl\u00f3czky, Z. (2011). Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027196"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/brain\/awq385","article-title":"In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis","volume":"134","author":"Goffin","year":"2011","journal-title":"Brain"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0896-6273(03)00499-9","article-title":"Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures","volume":"39","author":"Chen","year":"2003","journal-title":"Neuron"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1523\/JNEUROSCI.3966-06.2007","article-title":"Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures","volume":"27","author":"Chen","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"\u03949-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression In Vitro and In Vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","article-title":"Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease","volume":"100","author":"McKallip","year":"2002","journal-title":"Blood"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Godhwani, N., and Bahna, S.L. (2018). Immune Dysregulation in Epilepsy. Neuroinflammation, Elsevier.","DOI":"10.1016\/B978-0-12-811709-5.00011-9"},{"key":"ref_202","first-page":"12","article-title":"Cannabinoids for pediatric epilepsy? Up in smoke or real science?","volume":"4","author":"Filloux","year":"2015","journal-title":"Transl. Pediatrics"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Shapiro, L., Wong, J.C., and Escayg, A. (2019). Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice. Epilepsia.","DOI":"10.1111\/epi.16388"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eplepsyres.2018.10.002","article-title":"The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus","volume":"148","author":"Wu","year":"2018","journal-title":"Epilepsy Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1528-1167.2009.02334.x","article-title":"Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy","volume":"51","author":"Romigi","year":"2010","journal-title":"Epilepsia"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.expneurol.2010.01.021","article-title":"Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy","volume":"223","author":"Bhaskaran","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2015.11.045","article-title":"TRPV1 receptors augment basal synaptic transmission in CA1 and CA3 pyramidal neurons in epilepsy","volume":"314","author":"Saffarzadeh","year":"2016","journal-title":"Neuroscience"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2016.02.005","article-title":"Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy","volume":"122","author":"Carletti","year":"2016","journal-title":"Epilepsy Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12031-012-9878-2","article-title":"Increased Expression of TRPV1 in the Cortex and Hippocampus from Patients with Mesial Temporal Lobe Epilepsy","volume":"49","author":"Sun","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.neuroscience.2006.02.074","article-title":"Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain","volume":"139","author":"Cristino","year":"2006","journal-title":"Neuroscience"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Xapelli, S., Agasse, F., Sard\u00e0-Arroyo, L., Bernardino, L., Santos, T., Ribeiro, F.F., Valero, J., Bragan\u00e7a, J., Schitine, C., and de Melo Reis, R.A. (2013). Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures. PLoS ONE.","DOI":"10.1371\/journal.pone.0063529"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Compagnucci, C., Di Siena, S., Bustamante, M.B., Di Giacomo, D., Di Tommaso, M., Maccarrone, M., Grimaldi, P., and Sette, C. (2013). Type-1 (CB1) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054271"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1093\/cercor\/bhy258","article-title":"Neural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampus","volume":"28","author":"Zimmermann","year":"2018","journal-title":"Cereb. Cortex"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1096\/fj.06-6164fje","article-title":"Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation","volume":"20","author":"Palazuelos","year":"2006","journal-title":"FASEB J."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.mcn.2008.05.001","article-title":"A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner","volume":"38","author":"Goncalves","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1096\/fj.05-3995fje","article-title":"The endocannabinoid system drives neural progenitor proliferation","volume":"19","author":"Aguado","year":"2005","journal-title":"FASEB J."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1523\/JNEUROSCI.3101-05.2006","article-title":"The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells","volume":"26","author":"Aguado","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.plipres.2013.05.004","article-title":"Cannabinoid receptor signaling in progenitor\/stem cell proliferation and differentiation","volume":"52","author":"Bari","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biocel.2013.12.007","article-title":"Endocannabinoid signalling in neuronal migration","volume":"47","author":"Zhou","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Duff, G., Argaw, A., Cecyre, B., Cherif, H., Tea, N., Zabouri, N., Casanova, C., Ptito, M., and Bouchard, J.-F. (2013). Cannabinoid Receptor CB2 Modulates Axon Guidance. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070849"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4161\/cam.2.4.6749","article-title":"Cannabinoid signaling system: Does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?","volume":"2","year":"2008","journal-title":"Cell Adhes. Migr."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.conb.2008.08.007","article-title":"Wiring and firing neuronal networks: Endocannabinoids take center stage","volume":"18","author":"Harkany","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"P\u00e9bay, A., and Wong, R.C.B. (2017). Cannabinoids as Regulators of Neural Development and Adult Neurogenesis. Lipidomics of Stem Cells, Springer International Publishing.","DOI":"10.1007\/978-3-319-49343-5"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0021-8782.2004.00325.x","article-title":"Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo","volume":"205","author":"Begbie","year":"2004","journal-title":"J. Anat."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1073\/pnas.0803545105","article-title":"Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1073\/pnas.0509494102","article-title":"Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor","volume":"102","author":"Berghuis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mcn.2008.02.001","article-title":"The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation","volume":"38","author":"Watson","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_228","first-page":"4565","article-title":"Cannabis \u201cin utero\u201d: The fetus as a compulsive consumer","volume":"6","author":"Ciampo","year":"2019","journal-title":"Int. J. Med Sci. Clin. Invent."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pnpbp.2013.09.014","article-title":"Prenatal cannabis exposure and infant outcomes: Overview of studies","volume":"52","author":"Huizink","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/fnl.11.27","article-title":"Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain","volume":"6","author":"Wu","year":"2011","journal-title":"Future Neurol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2019.8734","article-title":"Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes","volume":"322","author":"Corsi","year":"2019","journal-title":"JAMA"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/jp.2015.120","article-title":"Association between marijuana use and adverse obstetrical and neonatal outcomes","volume":"35","author":"Warshak","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0892-0362(00)00066-0","article-title":"Effects of prenatal marijuana exposure on child behavior problems at age 10","volume":"22","author":"Goldschmidt","year":"2000","journal-title":"Neurotoxicol. Teratol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyy186","article-title":"Preconception and prenatal cannabis use and the risk of behavioural and emotional problems in the offspring; a multi-informant prospective longitudinal study","volume":"48","author":"Bolhuis","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.66.2.204","article-title":"A Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice","volume":"66","author":"Jin","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00516","article-title":"Interaction between cannabinoid type 1 and type 2 receptors in the modulation of subventricular zone and dentate gyrus neurogenesis","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Moreno-Jim\u00e9nez, E.P., Flor-Garc\u00eda, M., Terreros-Roncal, J., R\u00e1bano, A., Cafini, F., Pallas-Bazarra, N., \u00c1vila, J., and Llorens-Mart\u00edn, M. (2019). Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease. Nat. Med.","DOI":"10.1038\/s41591-019-0375-9"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00259-016-3457-7","article-title":"Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer\u2019s disease","volume":"43","author":"Ahmad","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.20699","article-title":"Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy","volume":"59","author":"Parent","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1460-9568.2009.06641.x","article-title":"Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein","volume":"29","author":"Marxreiter","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1096\/fasebj.14.10.1432","article-title":"Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson\u2019s disease","volume":"14","author":"Hill","year":"2000","journal-title":"FASEB J."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.phrs.2007.09.008","article-title":"Endocannabinoids and neurodegenerative diseases","volume":"56","author":"Micale","year":"2007","journal-title":"Pharmacol. Res."},{"key":"ref_243","first-page":"109","article-title":"The Endocannabinoid System and Neurogenesis in Health and Disease","volume":"13","author":"Aguado","year":"2007","journal-title":"Neuroscience"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coph.2019.11.002","article-title":"Endocannabinoid system and adult neurogenesis: A focused review","volume":"50","author":"Oddi","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.127.12.2593","article-title":"Presenilin-1 regulates neuronal differentiation during neurogenesis","volume":"127","author":"Handler","year":"2000","journal-title":"Development"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Zhang, J., Ooi, J., Utami, K.H., Langley, S.R., Aning, O.A., Park, D.S., Renner, M., Ma, S., Cheok, C.F., and Knoblich, J.A. (2019). Expanded huntingtin CAG repeats disrupt the balance between neural progenitor expansion and differentiation in human cerebral organoids. bioRxiv, 850586.","DOI":"10.1101\/850586"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1134\/S1819712417040092","article-title":"The effects of \u03b1-synuclein oligomers on neurogenesis in the hippocampus and the behavior of aged mice","volume":"11","author":"Sherstnev","year":"2017","journal-title":"Neurochem. J."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson\u2019s Disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bcp.2018.08.007","article-title":"Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model","volume":"157","author":"Aso","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2019.03.027","article-title":"Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons","volume":"150","author":"Maroto","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00733","article-title":"The Endocannabinoid System and Oligodendrocytes in Health and Disease","volume":"12","author":"Ilyasov","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"De Oliveira, R.W., Oliveira, C.L., Guimar\u00e3es, F.S., and Campos, A.C. (2018). Cannabinoid signalling in embryonic and adult neurogenesis: Possible implications for psychiatric and neurological disorders. Acta Neuropsychiatr., 1\u201316.","DOI":"10.1017\/neu.2018.11"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.yebeh.2016.11.012","article-title":"Cannabinoids in treatment-resistant epilepsy: A review","volume":"70","author":"Gloss","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2016.03.005","article-title":"Cannabidiol and epilepsy: Rationale and therapeutic potential","volume":"107","author":"Leo","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","article-title":"Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection","volume":"70","author":"Rosenberg","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s11064-011-0479-1","article-title":"Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat","volume":"36","author":"Naderi","year":"2011","journal-title":"Neurochem. Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eplepsyres.2012.11.006","article-title":"Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats","volume":"104","author":"Vilela","year":"2013","journal-title":"Epilepsy Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eplepsyres.2017.09.017","article-title":"Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid\u2013induced damage to hippocampal neurons: Dependence on the degree of injury","volume":"137","author":"Mikheeva","year":"2017","journal-title":"Epilepsy Res."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2012.02.003","article-title":"Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures","volume":"100","author":"Manna","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Griebel, G., Pichat, P., Beesk\u00e9, S., Leroy, T., Redon, N., Jacquet, A., Fran\u00e7on, D., Bert, L., Even, L., and Lopez-Grancha, M. (2015). Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. Sci. Rep., 5.","DOI":"10.1038\/srep07642"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuron.2014.06.030","article-title":"ABHD6 Blockade Exerts Antiepileptic Activity in PTZ-Induced Seizures and in Spontaneous Seizures in R6\/2 Mice","volume":"83","author":"Naydenov","year":"2014","journal-title":"Neuron"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2015.07.028","article-title":"ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs","volume":"1624","author":"Zagaja","year":"2015","journal-title":"Brain Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2018.12.016","article-title":"Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain","volume":"696","author":"Zagaja","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"107849","DOI":"10.1016\/j.neuropharm.2019.107849","article-title":"Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain","volume":"163","author":"Szewczyk","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Andres-Mach, M., Zagaja, M., Haratym-Maj, A., Rola, R., Maj, M., Haratym, J., Dudra-Jastrz\u0119bska, M., and \u0141uszczki, J. (2017). A Long-Term Treatment with Arachidonyl-2\u2032-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050900"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"136","DOI":"10.26444\/jpccr\/81283","article-title":"Increased neurogenesis after ACEA and levetiracetam treatment in mouse pilocarpine model of epilepsy","volume":"11","author":"Zagaja","year":"2017","journal-title":"J. Pre Clin. Clin. Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pnpbp.2012.07.001","article-title":"Effect of ACEA\u2014A selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model","volume":"39","author":"Zolkowska","year":"2012","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2014.10.018","article-title":"Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats","volume":"73","author":"Cannon","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1021\/acschemneuro.9b00080","article-title":"WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT2C\/NMDA\/CB1\/Receptors in the Rat Hippocampus","volume":"10","author":"Colangeli","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00702-008-0076-x","article-title":"Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice","volume":"115","author":"Naderi","year":"2008","journal-title":"J. Neural Transm."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2011.01.002","article-title":"Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"98","author":"Luszczki","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","article-title":"Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice","volume":"720","author":"Luszczki","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_274","first-page":"115","article-title":"Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice","volume":"14","author":"Naderi","year":"2015","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2008.04.010","article-title":"The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice","volume":"81","author":"Bahremand","year":"2008","journal-title":"Epilepsy Res."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2009.01.003","article-title":"Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice","volume":"84","author":"Bahremand","year":"2009","journal-title":"Epilepsy Res."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eplepsyres.2016.08.011","article-title":"The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats","volume":"127","author":"Hoeller","year":"2016","journal-title":"Epilepsy Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/epi.13842","article-title":"Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats","volume":"58","author":"Huizenga","year":"2017","journal-title":"Epilepsia"},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Malyshevskaya, O., Aritake, K., Kaushik, M.K., Uchiyama, N., Cherasse, Y., Kikura-Hanajiri, R., and Urade, Y. (2017). Natural (\u22069-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-10447-2"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Breivogel, C.S., Wells, J.R., Jonas, A., Mistry, A.H., Gravley, M.L., Patel, R.M., Whithorn, B.E., and Brenseke, B.M. (2019). Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with \u03949-Tetrahydrocannabinol. Cannabis Cannabinoid Res.","DOI":"10.1089\/can.2019.0003"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/adb.12334","article-title":"Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid \u2018Spice\u2019 compounds: Comparison with \u03949-tetrahydrocannabinol: Spice and hippocampal function","volume":"22","author":"Hoffman","year":"2017","journal-title":"Addict. Biol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1073\/pnas.1514962112","article-title":"Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons","volume":"112","author":"Remmers","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nlm.2016.12.023","article-title":"Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal \u03949-THC exposure","volume":"139","author":"Beggiato","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.phrs.2009.11.008","article-title":"Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to \u03949-THC","volume":"61","author":"Castaldo","year":"2010","journal-title":"Pharmacol. Res."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","article-title":"Cannabidivarin is anticonvulsant in mouse and rat","volume":"167","author":"Hill","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_287","unstructured":"Whalley, B., Williams, C., Stephens, G., and Futamura, T. (2015). Use of the Phytocannabinoid Cannabidivarin (CBDV) in the Treatment of Epilepsy. (No. 9,125,859), U.S. Patent."},{"key":"ref_288","unstructured":"Henley, B. (2018). Characterising the Anti-Convulsant Effects of CBD and CBDV on Layer II of the Medial Entorhinal Cortex of Rat and Human Brain Tissue In Vitro. [Ph.D. Thesis, Aston University]."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.clinph.2015.10.060","article-title":"The anticonvulsant effects of cannabidiol examined in animal seizure models","volume":"127","author":"Thompson","year":"2016","journal-title":"Clin. Neurophysiol."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"do val-da Silva, R.A., Peixoto-Santos, J.E., Kandratavicius, L., de Ross, J.B., Esteves, I., de Martinis, B.S., Alves, M.N.R., Scandiuzzi, R.C., Hallak, J.E.C., and Zuardi, A.W. (2017). Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00131"},{"key":"ref_291","doi-asserted-by":"crossref","unstructured":"Kozela, E., Juknat, A., and Vogel, Z. (2017). Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081669"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/bph.14202","article-title":"Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model: Antiepileptic\/neuroprotective effects of CBD in hippocampus","volume":"175","author":"Khan","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1074248414532013","article-title":"The Effect of Cannabidiol on Ischemia\/Reperfusion-Induced Ventricular Arrhythmias: The Role of Adenosine A1 Receptors","volume":"20","author":"Gonca","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"106734","DOI":"10.1016\/j.yebeh.2019.08.009","article-title":"The Proposed Multimodal Mechanism of Action of Cannabidiol (CBD) in Epilepsy: Modulation of Intracellular Calcium and Adenosine-mediated Signalling","volume":"101","author":"Stott","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts \u03949-Tetrahydrocannabinol-Induced Cognitive Impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Wilson, C.N., and Mustafa, S.J. (2009). Adenosine Receptors and the Central Nervous System. Adenosine Receptors in Health and Disease. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/978-3-540-89615-9"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hipo.22392","article-title":"Synaptic mechanisms of adenosine A2A receptor-mediated hyperexcitability in the hippocampus: Synapse-Specific Modulation Via A2AR","volume":"25","author":"Rombo","year":"2015","journal-title":"Hippocampus"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/glia.23694","article-title":"Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists","volume":"67","author":"Franco","year":"2019","journal-title":"Glia"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.celrep.2018.02.004","article-title":"Noninflammatory Changes of Microglia Are Sufficient to Cause Epilepsy","volume":"22","author":"Zhao","year":"2018","journal-title":"Cell Rep."},{"key":"ref_301","doi-asserted-by":"crossref","unstructured":"Eyo, U.B., Peng, J., Murugan, M., Mo, M., Lalani, A., Xie, P., Xu, P., Margolis, D.J., and Wu, L.-J. (2016). Regulation of Physical Microglia\u2013Neuron Interactions by Fractalkine Signaling after Status Epilepticus. Eneuro, 3.","DOI":"10.1523\/ENEURO.0209-16.2016"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semcdb.2019.05.017","article-title":"Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission","volume":"94","author":"Marinelli","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41583-019-0126-4","article-title":"Neuron\u2013glia interactions in the pathophysiology of epilepsy","volume":"20","author":"Patel","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_304","unstructured":"(2019, December 01). Search of: Cannabinoids Epilepsy-List Results-ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/results?term=cannabinoids+epilepsy&Search=Search."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41586-019-02524-5","article-title":"The reality behind cannabidiol\u2019s medical hype","volume":"572","author":"Eisenstein","year":"2019","journal-title":"Nature"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00441-017-2675-z","article-title":"Neural stem cells and epilepsy: Functional roles and disease-in-a-dish models","volume":"371","author":"Thodeson","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_307","first-page":"167","article-title":"Efficacy of cannabinoids in pharmacoresistant epilepsy: A narrative review of the literature","volume":"33","author":"Ferreiros","year":"2020","journal-title":"Iatreia"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","article-title":"Cannabinoids promote oligodendrocyte progenitor survival: Involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling","volume":"22","author":"Vela","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: Potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_310","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Ruiz, J., Galve-Roperh, I., Sagredo, O., and Guzm\u00e1n, M. (2020). Possible therapeutic applications of cannabis in the neuropsychopharmacology field. Eur. Neuropsychopharmacol.","DOI":"10.1016\/j.euroneuro.2020.01.013"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1134\/S1819712410020029","article-title":"Aberrant neurogenesis in adult epileptic brain: Compensatory or pathologic","volume":"4","author":"Gulyaeva","year":"2010","journal-title":"Neurochem. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7309\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:16:15Z","timestamp":1760177775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":311,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21197309"],"URL":"https:\/\/doi.org\/10.3390\/ijms21197309","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]}}}